
Personalized Medicine: Our Mission
The Center for Applied Proteomics and Molecular Medicine’s (CAPMM) mission is to:
- Create new technologies and make basic science discoveries in the field of disease pathogenesis
- Apply these discoveries and technologies to create and implement strategies for disease prevention, early diagnosis and individualized therapy.
The primary emphasis of our disease research is cancer, but new technologies developed in the center are being applied to a number of important human diseases including cardiovascular disease, diabetes, and obesity, as well as liver, ocular, neurodegenerative and infectious diseases.
Personalized medicine strives to provide the right medicine for the right patient with the lowest toxicity. Research, like that being done by the Center for Applied Proteomics and Molecular Medicine, provides strategies for personalized treatment with the goal of providing physicians key missing molecular information about the disease in each of their patients and improving the quality of life for patients.
Research and Technology
Personalized medicine strives to provide the right medicine for the right patient with the lowest toxicity. Take a minute to view all the progress our team is doing in the field of Personalized Medicine.
View all of our research:
Publications
View all published works over the years from our dedicated research teams.
View Publications:
Educational Advancement
Are you a graduate student or undergraduate lookin for way to work with CAPMM, or the courses the researchers from our program teach?
View all Education information:
- Congresswoman Jennifer Wexton helps Mason land federal funding for projects to benefit the well-being of residents across the stateCongresswoman Jennifer Wexton helps Mason land federal funding for projects to benefit the well-being of residents across the state Colleen Rich Mon, 01/30/2023 – 13:08 […]
- Alessandra Luchini honored by SCHEV with Outstanding Faculty AwardAlessandra Luchini honored by SCHEV with Outstanding Faculty Award Melanie Balog Thu, 01/12/2023 – 16:50 Body George Mason University’s Alessandra Luchini is among the 12 […]
- Mason team is one of 10 Phase 1 winners of the LymeX Diagnostics PrizeMason team is one of 10 Phase 1 winners of the LymeX Diagnostics Prize John Hollis Tue, 12/06/2022 – 10:44 In This Story People Mentioned […]